[Problems in the treatment of cardiogenic shock].
D000804:Angiotensin II / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications; D009638:Norepinephrine / Q000627:therapeutic use*; D012770:Shock, Cardiogenic / Q000188:drug therapy* / Q000378:metabolism; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D014662:Vasoconstrictor Agents; D000804:Angiotensin II; D009638:Norepinephrine
Zur Problematik er Behandlung des kardiogenen Schocks.